Comparison of time to recovery by sugammadex vs neostigmine for vecuronium reversal in patients undergoing laparoscopic cholecystectomy.

Comparison study of time to recovery by sugammadex vs neostigmine for vecuronium reversal in patients undergoing laparoscopic cholecystectomy A Randomized controlled trail. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/12/078585

Enrollment

Registered

2024-12-26

Start date

Unknown

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: REVERSAL OF NEUROMUSCULAR BLOCKADE IN GENERAL ANESTHESIA.: Patient undergoing Laparoscopic cholecystectomy under General Anesthesia at the time of reversal we will give Inj Neostigmine

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age : 18 to 65 years 2. ASA I, ASA II and ASA III 3. Elective Laparoscopic cholecystectomy surgery 4. MPG I, II

Exclusion criteria

Exclusion criteria: 1.Patients with neuromuscular diseases 2.Patients using medications that influence neuromuscular functions (e.g:-Calcium channel blockers, magnesium supplements , phenytoin, amino glycoside) 3.Electrolytes abnormalities 4.Hepatic or renal insufficiency 5.Patients with known allergies to medications used in the study 6.Laparoscopic cholecystectomy converted to open surgery.

Design outcomes

Primary

Measure	Time frame
To compare the Time to recovery provided by Sugammadex and Neostigmine in Vecuronium induced Neuromuscular blockade in patient undergoing laparoscopic cholecystectomy.Timepoint: 5 min	—

Secondary

Measure	Time frame
To moniter Hemodynamics changes with extubation.Timepoint: 4 hrs;To moniter for any Residual neuromuscular blockade.Timepoint: 6 hrs	—

Countries

India

Contacts

Public ContactDr RANJITH KUMAR

Aarupadai veedu medical College and hospital

gautampranava@gmail.com9786610917

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026